UNSPSC 85603308: Revision of infusion device in lower intestinal tract, via natural or artificial opening endoscopic

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in lower intestinal tract, via natural or artificial opening endoscopic. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0DWD83Z

UNSPSC 85603308 Revision of infusion device in lower intestinal tract, via natural or artificial opening endoscopic (Commodity) shows little relevant recent activity under the code's nominal medical device scope. The recent opportunities posted under this code reflect a categorical mismatch: they solicit independent medical evaluation services, occupational health surveillance, pharmacy benefit management, surgical center-of-excellence networks, temporary health professional staffing, and emergency medical services for detained youth—none of which involve infusion devices or lower intestinal tract procedures. The code appears to have been applied to healthcare and benefits administration opportunities rather than to the procedural medical device work its title describes, creating a taxonomy misalignment that renders the recent solicitations uninformative for vendors pursuing endoscopic infusion device work.

The issuing bodies posting under this code span state and county health systems and retirement offices, including the City of Phoenix Retirement Office (Arizona), the City of Long Beach (California), the Washington State Department of Transportation (Washington), Harris County Juvenile Probation Department (Texas), Collier County Board of County Commissioners (Florida), and the County of Santa Clara Health System (California). Recent postings date from July through October 2026, with response dates between September 25 and October 16, 2026. The geographic distribution spans Arizona, California, Florida, Texas, and Washington; however, absent clarification on the true scope of procurement under this code, the recent activity provides no actionable signal for business development focused on endoscopic infusion devices or related lower intestinal interventions in state and local markets.